Rheinmetall's Bundeswehr Pipeline Keeps Flowing, Even as the Share Price Tells a Rougher Story

Rheinmetall wins €500M Bundeswehr field hospital contract, boosting order book to €80B despite F126 setback; stock remains volatile.

The order intake at Rheinmetall shows no sign of letting up. Fresh off a contract to modernise the frigate Bayern — a mid-three-digit million euro deal that will keep the Neuen Jadewerft in Wilhelmshaven busy until 2029 — the defence group has now confirmed another Bundeswehr mandate worth more than €500 million, this time for mobile field hospitals.

That medical equipment order was booked back in July and could grow further: with an option for additional units, the gross volume climbs past €600 million. Production is slated to begin in the first quarter of 2027.

The two announcements, landing within days of each other, sketch a clear picture of a company leaning hard into portfolio diversification. The frigate modernisation, which extends the vessel's service life to 2035, arrived as a direct counterweight to a far larger disappointment: the cancellation of the F126 frigate programme at the end of June, a project worth roughly €20 billion. The new work does not come close to replacing that lost volume, but it does signal that Rheinmetall remains a preferred partner in naval modernisation.

The Bundeswehr is also leaning on the group for logistics and heavy equipment. Rheinmetall recently delivered 56 additional Elefant-2 heavy transporters, a €60.5 million gross extension of a framework agreement that originally covered up to 137 vehicles. Add the field hospital contract, and the portfolio now spans everything from armoured vehicles and naval systems to battlefield medical infrastructure.

That breadth is the core of the investment story. Rheinmetall's order book stands at more than €80 billion, bolstered lately by a loitering munitions contract and a €11.371 billion SAFE package with Romania. Even with the F126 setback, the visibility across the coming years remains unusually high.

Management is also signalling confidence in its own trajectory. After the F126 shock, CEO Armin Papperger bought roughly €3 million worth of shares through his holding company, ATP Holding GmbH — a move analysts read as a vote of faith in the long-term direction of the business.

The share price, however, has been a more complicated affair. On Tuesday, the stock traded at €1,211.80, down 0.4 percent on the day. That follows a dramatic week: despite what the company called the best quarter in its 137-year history, the shares briefly tumbled 8.5 percent last Thursday before staging a recovery. The stock now sits at €1,214.00, up 6.3 percent on the week and 23 percent over the past month. Still, it remains 40 percent below its 52-week high of €2,007.00 from October, and down 22 percent since the start of the year.

The disconnect between operational momentum and market sentiment is not lost on investors. The recent wave of contracts — from the frigate work to the field hospitals — provides tangible evidence of earnings power beyond the forecast debates that have weighed on the stock. But the valuation question persists, and the market will be watching closely whether Rheinmetall can convert its interest in Volkswagen's Osnabrück site for military vehicle production, and its exposure to the fast-growing drone defence market, into further concrete wins.

For now, the pipeline is the anchor. The steady drumbeat of orders, even after major programme cancellations, suggests the group has built a resilience that goes beyond any single contract.